Literature DB >> 18374720

Transrectal ultrasound-guided biopsy of the prostate: aspirin increases the incidence of minor bleeding complications.

O T Halliwell1, G Yadegafar, C Lane, K C Dewbury.   

Abstract

AIM: To assess whether patients taking aspirin were more likely to experience bleeding complications after transrectal ultrasound (TRUS)-guided prostate biopsy.
MATERIALS AND METHODS: Three hundred and eighty-seven patients taking aspirin who underwent prostate biopsy over a 3.5 year period and 731 patients not taking aspirin over a 2 year period returned a questionnaire assessing the incidence and severity of bleeding complications.
RESULTS: Patients taking aspirin had a significantly higher cumulative incidence of haematuria and rectal bleeding, but not of haemospermia. They also had a longer mean duration of bleeding, but no increase in bleeding severity. Severe bleeding was very uncommon in both groups and no patients required intervention for bleeding complications.
CONCLUSION: Aspirin exacerbates minor bleeding complications in patients undergoing TRUS guided biopsy of the prostate, but in this large group of aspirin-taking patients no dangerous bleeding complications were encountered. It may be that the risks associated with aspirin cessation outweigh the risks of haemorrhagic complications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18374720     DOI: 10.1016/j.crad.2007.09.014

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  14 in total

1.  Discontinuation of anticoagulant or antiplatelet therapy for transrectal ultrasound-guided prostate biopsies: a single-center experience.

Authors:  Omer A Raheem; Rowan G Casey; David J Galvin; Rustom P Manecksha; Haradikar Varadaraj; Ted McDermott; Ronald Grainger; Thomas H Lynch
Journal:  Korean J Urol       Date:  2012-04-18

2.  [ASA and clopidogrel for urological operations. Perioperative management].

Authors:  C Fischer; G Lümmen
Journal:  Urologe A       Date:  2013-11       Impact factor: 0.639

3.  Natural history of prostatic lesions on serial multiparametric magnetic resonance imaging.

Authors:  Samrad Ghavimi; Hamidreza Abdi; Jennifer Waterhouse; Richard Savdie; Silvia Chang; Alison Harris; Lindsay Machan; Martin Gleave; Alan I So; Larry Goldenberg; Peter C Black
Journal:  Can Urol Assoc J       Date:  2018-04-06       Impact factor: 1.862

Review 4.  The management of rectal bleeding following transrectal prostate biopsy: A review of the current literature.

Authors:  Mark R Quinlan; Damien Bolton; Rowan G Casey
Journal:  Can Urol Assoc J       Date:  2017-12-22       Impact factor: 1.862

5.  The effect of ultrasound-guided compression immediately after transrectal ultrasound-guided prostate biopsy on postbiopsy bleeding: a randomized controlled pilot study.

Authors:  Bong Hee Park; Jung Im Kim; Sang Rak Bae; Yong Seok Lee; Sung Hak Kang; Chang Hee Han
Journal:  Int Urol Nephrol       Date:  2017-05-04       Impact factor: 2.370

6.  Massive rectal bleeding after prostate biopsy controlled by endoclipping in a patient using acetylsalicylic acid.

Authors:  Bora Ozveren; Levent Türkeri
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

Review 7.  Optimization of prostate biopsy: review of technique and complications.

Authors:  Marc A Bjurlin; James S Wysock; Samir S Taneja
Journal:  Urol Clin North Am       Date:  2014-05       Impact factor: 2.241

8.  Continued administration of antithrombotic agents during transperineal prostate biopsy.

Authors:  Toko Asano; Shuichiro Kobayashi; Masataka Yano; Yukihiro Otsuka; Satoshi Kitahara
Journal:  Int Braz J Urol       Date:  2015 Jan-Feb       Impact factor: 1.541

9.  Antiplatelet drugs and the perioperative period: What every urologist needs to know.

Authors:  Pawan Vasudeva; Apul Goel; Vengetesh K Sengottayan; Satyanarayan Sankhwar; Divakar Dalela
Journal:  Indian J Urol       Date:  2009-07

10.  Safety of 12 core transrectal ultrasound guided prostate biopsy in patients on aspirin.

Authors:  Pawan Vasudeva; Niraj Kumar; Anup Kumar; Harbinder Singh; Gaurav Kumar
Journal:  Int Braz J Urol       Date:  2015 Nov-Dec       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.